Annual Cash & Cash Equivalents
$12.60 M
+$6.72 M+114.41%
31 December 2023
Summary:
ProMIS Neurosciences annual cash & cash equivalents is currently $12.60 million, with the most recent change of +$6.72 million (+114.41%) on 31 December 2023. During the last 3 years, it has risen by +$11.79 million (+1461.30%). PMN annual cash & cash equivalents is now -25.65% below its all-time high of $16.94 million, reached on 31 December 2021.PMN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$21.54 M
+$20.54 M+2069.96%
30 September 2024
Summary:
ProMIS Neurosciences quarterly cash and cash equivalents is currently $21.54 million, with the most recent change of +$20.54 million (+2069.96%) on 30 September 2024. Over the past year, it has increased by +$4.67 million (+27.68%). PMN quarterly cash and cash equivalents is now -78.92% below its all-time high of $102.17 million, reached on 01 September 2003.PMN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +114.4% | +27.7% |
| 3 y3 years | +1461.3% | +3.6% |
| 5 y5 years | +618.0% | +7897.4% |
PMN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.6% | +1461.3% | at high | +2070.0% |
| 5 y | 5 years | -25.6% | +1461.3% | at high | +8573.7% |
| alltime | all time | -25.6% | >+9999.0% | -78.9% | >+9999.0% |
ProMIS Neurosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.54 M(+2070.0%) |
| June 2024 | - | $992.50 K(-60.3%) |
| Mar 2024 | - | $2.50 M(-80.2%) |
| Dec 2023 | $12.60 M(+114.4%) | $12.60 M(-25.3%) |
| Sept 2023 | - | $16.87 M(+1279.6%) |
| June 2023 | - | $1.22 M(-63.3%) |
| Mar 2023 | - | $3.33 M(-43.3%) |
| Dec 2022 | $5.88 M(-65.3%) | $5.88 M(+49.9%) |
| Sept 2022 | - | $3.92 M(-56.0%) |
| June 2022 | - | $8.90 M(-35.3%) |
| Mar 2022 | - | $13.76 M(-18.8%) |
| Dec 2021 | $16.94 M(+1999.9%) | $16.94 M(-18.5%) |
| Sept 2021 | - | $20.78 M(+272.6%) |
| June 2021 | - | $5.58 M(-19.9%) |
| Mar 2021 | - | $6.96 M(+762.5%) |
| Dec 2020 | $806.90 K(-36.6%) | $806.90 K(+225.0%) |
| Sept 2020 | - | $248.30 K(-73.0%) |
| June 2020 | - | $918.20 K(+5.7%) |
| Mar 2020 | - | $869.00 K(-31.7%) |
| Dec 2019 | $1.27 M(-27.5%) | - |
| Dec 2019 | - | $1.27 M(+372.4%) |
| Sept 2019 | - | $269.30 K(-71.4%) |
| June 2019 | - | $941.70 K(-21.2%) |
| Mar 2019 | - | $1.19 M(-31.9%) |
| Dec 2018 | $1.75 M(+30.6%) | - |
| Dec 2018 | - | $1.75 M(-51.3%) |
| Sept 2018 | - | $3.60 M(-30.4%) |
| June 2018 | - | $5.18 M(+304.6%) |
| Mar 2018 | - | $1.28 M(-4.8%) |
| Dec 2017 | $1.34 M(+153.6%) | $1.34 M(-49.3%) |
| Sept 2017 | - | $2.65 M(+405.0%) |
| June 2017 | - | $524.40 K(-65.5%) |
| Mar 2017 | - | $1.52 M(+186.8%) |
| Dec 2016 | $529.80 K(-18.6%) | $529.80 K(-53.2%) |
| Sept 2016 | - | $1.13 M(+107.7%) |
| June 2016 | - | $545.40 K(-30.5%) |
| Mar 2016 | - | $785.20 K(+20.6%) |
| Dec 2015 | $650.90 K(+2927.4%) | $650.90 K(-38.5%) |
| Sept 2015 | - | $1.06 M(>+9900.0%) |
| June 2015 | - | $1400.00(-70.8%) |
| Mar 2015 | - | $4800.00(-92.4%) |
| Dec 2014 | $21.50 K(-82.6%) | - |
| Sept 2014 | - | $63.30 K(-84.2%) |
| June 2014 | - | $401.40 K(+224.2%) |
| Mar 2014 | $123.80 K | $123.80 K(+162.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $47.10 K(+262.3%) |
| Sept 2013 | - | $13.00 K(-90.5%) |
| June 2013 | - | $137.20 K(+285.4%) |
| Mar 2013 | $35.60 K(-95.6%) | $35.60 K(-68.4%) |
| Dec 2012 | - | $112.80 K(-80.3%) |
| Sept 2012 | - | $571.60 K(-50.1%) |
| June 2012 | - | $1.15 M(+40.2%) |
| Mar 2012 | $817.40 K(-59.9%) | $817.40 K(+49.2%) |
| Dec 2011 | - | $547.70 K(-26.9%) |
| Sept 2011 | - | $749.70 K(-32.2%) |
| June 2011 | - | $1.11 M(-45.7%) |
| Mar 2011 | $2.04 M(+769.0%) | $2.04 M(-4.8%) |
| Dec 2010 | - | $2.14 M(+35.6%) |
| Sept 2010 | - | $1.58 M(+134.4%) |
| June 2010 | - | $673.50 K(+187.3%) |
| Mar 2010 | $234.40 K(-47.6%) | $234.40 K(-82.6%) |
| Dec 2009 | - | $1.35 M(-39.8%) |
| Sept 2009 | - | $2.24 M(-11.1%) |
| June 2009 | - | $2.51 M(+462.2%) |
| Mar 2009 | $447.10 K(-79.2%) | $447.10 K(-58.2%) |
| Dec 2008 | - | $1.07 M(-6.8%) |
| Sept 2008 | - | $1.15 M(+96.3%) |
| June 2008 | - | $583.80 K(-72.8%) |
| Mar 2008 | $2.15 M(+49.3%) | $2.15 M(-8.4%) |
| Dec 2007 | - | $2.35 M(-29.4%) |
| Sept 2007 | - | $3.32 M(+220.1%) |
| June 2007 | - | $1.04 M(-27.9%) |
| Mar 2007 | $1.44 M(+1374.9%) | $1.44 M(-27.6%) |
| Dec 2006 | - | $1.99 M(+96.9%) |
| Sept 2006 | - | $1.01 M(-73.2%) |
| June 2006 | - | $3.77 M(+3757.9%) |
| Mar 2006 | $97.60 K | $97.60 K(+0.4%) |
| Dec 2005 | - | $97.20 K(+80.3%) |
| Sept 2005 | - | $53.90 K(-42.7%) |
| June 2005 | - | $94.00 K(-99.9%) |
| June 2004 | - | $102.00 M(+88.8%) |
| Mar 2004 | - | $54.01 M(+43.9%) |
| Dec 2003 | - | $37.53 M(-63.3%) |
| Sept 2003 | - | $102.17 M(+2.0%) |
| June 2003 | - | $100.18 M(>+9900.0%) |
| Dec 2002 | - | $118.00 K(-22.6%) |
| June 2002 | - | $152.40 K(+577.3%) |
| Dec 2001 | - | $22.50 K(-81.4%) |
| June 2001 | - | $121.00 K(+49.0%) |
| Dec 2000 | - | $81.20 K(-77.6%) |
| June 2000 | - | $362.90 K |
FAQ
- What is ProMIS Neurosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual cash & cash equivalents year-on-year change?
- What is ProMIS Neurosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly cash and cash equivalents year-on-year change?
What is ProMIS Neurosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of PMN is $12.60 M
What is the all time high annual cash & cash equivalents for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual cash & cash equivalents is $16.94 M
What is ProMIS Neurosciences annual cash & cash equivalents year-on-year change?
Over the past year, PMN annual cash & cash equivalents has changed by +$6.72 M (+114.41%)
What is ProMIS Neurosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PMN is $21.54 M
What is the all time high quarterly cash and cash equivalents for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly cash and cash equivalents is $102.17 M
What is ProMIS Neurosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, PMN quarterly cash and cash equivalents has changed by +$4.67 M (+27.68%)